Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

SNY stock hub

Sanofi has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SNYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

103.3B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SNY

In the news

Latest news · SNY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.5

P25 12.3P50 18.4P75 33.1

Trailing P/E11.9

P25 14.9P50 23.2P75 38.5

ROE6.6

P25 -105.6P50 -46.5P75 -3.1

ROIC9.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SNY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

267

Groups with data

Currency

EUR

Showing 267 of 267 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001121404
Company name	Sanofi
Country	France
Country code	US
Cusip	80105N105
Employees	74,846
Employees Change	-8,032%
Employees Change Percent	-9.69
Enterprise value	$120.7B
Exchange	NASDAQ
Financial currency	EUR
First seen	2026-05-09
Industry	Drug Manufacturers - General
Isin	US80105N1054
Last refreshed	2026-05-10
Market cap	$103.3B
Market cap category	Large-Cap
Price	$43.31
Price currency	USD
Rev Per Employee	729,488.97x
Sector	Healthcare
Sic	2834
Symbol	SNY
Website	https://www.sanofi.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.44%
EV Earnings	13.86x
EV Sales Forward	2.48x
EV/EBIT	10.79x
EV/EBITDA	8.16x
EV/FCF	11.93x
EV/Sales	2.21x
FCF yield	9.8%
Forward P/E	8.5x
P/B ratio	1.22x
P/E ratio	11.85x
P/S ratio	1.89x
PE Ratio10 Y	18.51x
PE Ratio3 Y	18.15x
PE Ratio5 Y	17.55x
PS Forward	2.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	20.49%
EBITDA Margin	27.09%
FCF margin	18.53%
Gross margin	72.36%
Gross Profit	$39.5B
Gross Profit Growth	6.9%
Gross Profit Growth Q	6.1%
Gross Profit Growth3 Y	1.98%
Gross Profit Growth5 Y	6.49%
Net Income	$8.7B
Net Income Growth	19.94%
Net Income Growth Q	-13.78%
Net Income Growth Years	2%
Net Income Growth3 Y	-3.31%
Net Income Growth5 Y	-9.14%
Pretax Margin	12.32%
Profit Margin	15.95%
Profit Per Employee	$116,385
Profitable Years	26
ROA	4.67
Roa5y	4.55
ROCE	9.9
ROE	6.58
Roe5y	8.3
ROIC	9.38
Roic5y	8.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.99%
Cagr15y	3.71%
Cagr1y	-11.12%
Cagr20y	2.49%
Cagr3y	-4.12%
Cagr5y	-0.51%
Div CAGR10	4.62%
Div CAGR3	8.72%
Div CAGR5	5.26%
EPS Growth	22.95
EPS Growth Q	-11.66
EPS Growth Years	2
EPS Growth3 Y	-2.29
EPS Growth5 Y	-8.52
FCF Growth	-8.29%
FCF Growth Q	-19.59%
OCF Growth	-6.73%
OCF Growth Q	-19.59%
Revenue Growth	4.84x
Revenue Growth Q	6.02x
Revenue Growth Years	5x
Revenue Growth3 Y	0.83x
Revenue Growth5 Y	5.09x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.36
Assets	$147.6B
Cash	$6.4B
Current Assets	$35.6B
Current Liabilities	$35.4B
Debt	$23.1B
Debt EBITDA	$1.53
Debt Equity	$0.27
Debt FCF	$2.28
Equity	$84.3B
Interest Coverage	18.84
Liabilities	$63.3B
Long Term Assets	$112B
Long Term Liabilities	$27.9B
Net Cash	$-16.7B
Net Cash By Market Cap	$-16.16
Net Debt EBITDA	$1.13
Net Debt Equity	$0.2
Net Debt FCF	$1.65
Tangible Book Value	$4.3B
Tangible Book Value Per Share	$3.56
WACC	5.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.01
Inventory Turnover	0.58
Net Working Capital	$914.3M
Quick ratio	0.2
Working Capital	$179.9M
Working Capital Turnover	$9.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.73%
Dividend Growth	10.52%
Dividend Growth Years	2%
Dividend per share	$1.77
Dividend Years	24
Dividend Yield	4.08%
Ex Div Date	2026-05-04
Last Dividend	$1.77
Payout Frequency	Annual
Payout Ratio	24.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	47.93%
1Y total return	-11.11%
200-day SMA	47.9
3Y total return	-11.85%
50-day SMA	45.95
50-day SMA vs 200-day SMA	50under200
5Y total return	-2.53%
All Time High	60.12
All Time High Change	-27.95%
All Time High Date	2025-03-10
All Time Low	22.53
All Time Low Change	92.23%
All Time Low Date	2003-02-13
ATR	0.9
Beta	0.32
Ch YTD	-10.63
High	43.31
High52	53.36
High52 Date	2025-05-21
High52ch	-18.83%
Low	42.78
Low52	42.78
Low52 Date	2026-05-08
Low52ch	1.24%
Ma50ch	-5.74%
Premarket Change Percent	-0.05
Premarket Price	$43.16
Premarket Volume	51,861
Price vs 200-day SMA	-9.58%
RSI	32.77
RSI Monthly	39.51
RSI Weekly	39.52
Sharpe ratio	-0.48x
Sortino ratio	-0.42
Total Return	6.81%
Tr YTD	-7.06
Tr15y	72.66%
Tr1m	-3.83%
Tr1w	-2.26%
Tr3m	-5.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	1
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$1.06
Earnings EPS Estimate Growth	12.77
Earnings Revenue Estimate	11,990,000,000x
Earnings Revenue Estimate Growth	15.22x
Operating Income	$11.2B
Operating Income Growth	1.78
Operating Income Growth Q	-7.22
Operating Income Growth3 Y	-4.91
Operating Income Growth5 Y	4.47
Operating margin	20.49
Price target	$58
Price Target Change	$33.92

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,083,780,676%
Float Percent	90%
Net Borrowing	1,773,664,385.9
Shares Insiders	0.02%
Shares Institutions	47.53%
Shares Out	1,204,200,000
Shares Qo Q	-0.7%
Shares Yo Y	-2.73%
Short Float	0.7%
Short Ratio	2.5
Short Shares	0.63

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$9.8B
Average Volume	2,665,140.05x
Bv Per Share	69.71
CAPEX	$-2B
Ch10y	11.19
Ch15y	9.48
Ch1m	-7.52
Ch1w	-6.01
Ch1y	-17.14
Ch20y	-10.48
Ch3m	-9.45
Ch3y	-22.34
Ch5y	-16.42
Ch6m	-12.79
Change	0.3%
Change From Open	0.46
Close	43.18
Days Gap	-0.16
Depreciation Amortization	3,684,127,354.8
Dollar Volume	108,956,223
Earnings Date	2026-04-23
Earnings Time	bmo
EBIT	$11.2B
EBITDA	$14.8B
EPS	$7.15
F Score	5
FCF	$10.1B
FCF EV Yield	8.38x
FCF Per Share	$8.4
Financing CF	-10,540,758,674
Fiscal Year End	December
Founded	1,994
Graham Number	53.92001
Graham Upside	24.5
Income Tax	$1.1B
Investing CF	-4,553,211,114
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-17
Lynch Fair Value	$18.27
Lynch Upside	-57.82
Ma150	47.8
Ma150ch	-9.39%
Ma20	46.11
Ma20ch	-6.08%
Net CF	-2,821,399,746
Next Earnings Date	2026-07-30
Open	43.11
Optionable	Yes
P FCF Ratio	10.21
P OCF Ratio	8.66
Payment Date	2026-06-03
Position In Range	100
Post Close	43.31
Postmarket Change Percent	0.42
Postmarket Price	$43.49
Ppne	13,767,126,357.1
Pre Close	43.18
Price Date	2026-05-08
Price EBITDA	$6.98
Ptbv Ratio	24.06
Relative Volume	0.94x
Revenue	54,599,331,243x
SBC By Revenue	0.66x
Share Based Comp	360,890,119
Tax By Revenue	2.07x
Tax Rate	16.83%
Tr20y	63.6%
Tr6m	-9.31%
Volume	2,515,729

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SNY dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.1%

$1.77 annual per share

Payout ratio

+24.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.3%

2 consecutive years of growth

Total shareholder yield

+6.8%

Next ex-dividend date: 2026-05-04

Performance

SNY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SNY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+47.5%

Float: +90.0% of shares outstanding

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SNY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.8

Neutral momentum band

Price vs 200-day MA

-9.6%

50/200-day relationship not available

Beta (5Y)

0.32

Less volatile than the market

Sharpe ratio

-0.48

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SNY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SNY stock rating?

Sanofi is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SNY analysis?

The full report lives at /stocks/SNY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SNY?

The latest report frames SNY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SNY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.